NCT04566393 2026-01-28
Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies
xCures
Available
Clinical Trials
11 trialsNCT05974410 2025-10-02
Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients
AVM Biotechnology Inc
Available
NCT06676891 2025-01-08
Expanded Access Program for GBM Subjects
Rznomics, Inc.
Available
NCT05936216 2024-10-01
TVI-Brain-1 in Expanded Access Patient
TVAX Biomedical
No longer available
NCT05551013 2024-08-09
Treatment of Recurrent GBM With APG-157 Via Expanded Access
Aveta Biomics, Inc.
No longer available
NCT04321694 2024-04-25
Expanded Access for KHK2455
Kyowa Kirin Co., Ltd.
No longer available
NCT04599647 2022-06-29
EAP for the Treatment of Glioblastoma With PVSRIPO
Istari Oncology, Inc.
No longer available
NCT04289155 2022-03-17
Individual Patient Compassionate Use of GX-I7
Genexine, Inc.
No longer available
NCT03460782 2019-11-08
An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and Gliomas
Center Trials & Treatment
No longer available
NCT03311542 2018-01-10
Expanded Access for Pembrolizumab (MK-3475)
Center Trials & Treatment
No longer available
NCT03068650 2017-10-18
CDX-110
Celldex Therapeutics
No longer available